Efficacy and safety of JMT103 in patients with bone metastases from solid tumors: A randomized Phase Ib clinical trial.
Ran R, Li H, Sun T, Zhou H, Zang A, Guo H, Xie H, Wu S, Yan Y, Yin X, Xiong H, Li H, Yuan J, Wang J, Li H, Li J.
Ran R, et al. Among authors: yan y.
Int J Cancer. 2025 Jan 23. doi: 10.1002/ijc.35343. Online ahead of print.
Int J Cancer. 2025.
PMID: 39853667